What is QCPRECISE!™ ?

The future of personalized medicine.

Applying high-tech machine learning & artificial intelligence, QuantumCyte pioneers our AI integrated platform (QCPRECISE!™) & automated tissue dissection in modern pathology for better patient outcomes. QCPRECISE!™ harnesses the power of AI for digital pathology to molecular analysis, to deliver precise & pure cellular data. This tool enables far superior diagnostic results, especially for cancer patients. Growth of personalized medicine demands large amounts of molecular data, and QuantumCyte is poised to address this global demand with their ability to extract highly precise molecular data. The technology is endorsed in both clinical and research markets.

Our Case Studies

Research and Drug Discovery
Bring precision to biomarker, drug discovery and companion diagnostics through
intelligent, automated tissue dissection

Expedite research with spatial information to develop disease understanding
Leverage AI to guide tissue microdissection, increase tumor purity, and generate actionable data from biopsies with low tumor content
Extract nucleic acid with the precision required for advanced NGS testing, RNA, DNA, and protein biomarkers analysis

Posters

[core needle Biopsies] and [TMAs – Tissue microarrays]
Tony early study poster (69% increase in VAF)
2020 AMP poster to NASH (AASLD poster)
Tumor buds (AMP/Mayo poster)
Jingyi poster – NPC, 2023
AZ poster at AMP 2023

Laboratory Medicine and Pathology
Capture the precision from the AI-based digital pathology to extract high quality samples
for molecular analysis

Increase efficiency through end-to-end automated tissue dissection from digital pathology to sample prep for downstream sequencing
Drive revenue by reducing inconclusive tests resulting from low tumor content and poor-quality tissue samples
Increase signal to noise and data quality for precision diagnostic
Lower cost and improve efficiency through scalable microdissection

Posters

[add Timothy poster title; poster at USCAP 2024]
Link to Tony (GI patient) – AMP 2020

Healthcare Providers
Make precision medicine possible for all patients with the right therapy to each individual
at the right time.

Accurately identify patients who will benefit from cutting-edge therapies
Reduce inconclusive genetic testing in difficult tissue samples such as QNS, FNA, and pleural
Reduce prebiopsy rates with actionable result the first time
Link to Tony (GI patient) – AMP 2020

Our Workflow

A precise and accurate workflow.

With conclusive results.

Innovative AI-integrated high-tech solutions can increase cellular purity and optimize molecular pathology workflows with improved accuracy, efficiency, and reliability, while avoiding the time-consuming, delicate, and risky process of tissue macro-dissection.